Volume 59, Issue 5, Pages 1935-1942 (May 2001) A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters Michele H. Mokrzycki, Kernilde Jean-Jerome, Heather Rush, Miroslaw P. Zdunek, Stuart O. Rosenberg Kidney International Volume 59, Issue 5, Pages 1935-1942 (May 2001) DOI: 10.1046/j.1523-1755.2001.0590051935.x Copyright © 2001 International Society of Nephrology Terms and Conditions
Figure 1 Patient identification and randomization. Kidney International 2001 59, 1935-1942DOI: (10.1046/j.1523-1755.2001.0590051935.x) Copyright © 2001 International Society of Nephrology Terms and Conditions
Figure 2 (A) Thrombosis-free tunneled cuffed catheter (TCC) survival comparing warfarin (dashed line) versus placebo (solid line). (B) Urokinase-free TCC survival comparing warfarin (dashed line) versus placebo (solid line). The analyses were performed using Cox regression, adjusted for aspirin use, hemoglobin, international normalized ratio (INR), diabetes, sex, and TCC infection. Kidney International 2001 59, 1935-1942DOI: (10.1046/j.1523-1755.2001.0590051935.x) Copyright © 2001 International Society of Nephrology Terms and Conditions
Figure 3 Thrombosis-free TCC survival according to the (A) mean INR and the (B) mean serum hemoglobin concentration. The analyses were performed using Cox regression, adjusted for aspirin use, warfarin administration, INR, hemoglobin, diabetes, sex, and TCC infection. Kidney International 2001 59, 1935-1942DOI: (10.1046/j.1523-1755.2001.0590051935.x) Copyright © 2001 International Society of Nephrology Terms and Conditions